🔎 Trials Near Me

Home › Plasma Cell Leukemia

Plasma Cell Leukemia clinical trials recruiting in the U.S.

8 studies for Plasma Cell Leukemia are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT07605416

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06517017

Allo HSCT Using RIC and PTCy for Hematological Diseases

RecruitingPhase 2
Up to age 75 · All sexes · Updated Jul 6, 2026 · NCT05805605

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

RecruitingPhase 2
Up to age 60 · All sexes · Updated Jun 25, 2026 · NCT03314974

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

RecruitingObservational study
Ages 50 and older · All sexes · Updated Dec 8, 2025 · NCT05556928

Registry for Adults With Plasma Cell Disorders (PCD's)

RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 20, 2025 · NCT03717844

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.